CEO says AstraZeneca likely to run new global trial of COVID-19 vaccine: Report
Published
A new study would be run to evaluate a lower dosage that performed better than a full amount in AstraZeneca`s studies.
Full ArticlePublished
A new study would be run to evaluate a lower dosage that performed better than a full amount in AstraZeneca`s studies.
Full ArticleWatch VideoAstraZeneca's CEO says the company needs to conduct another global trial for its vaccine. That's according to a report..
BEIJING (AP) — Asian stock markets were mixed Friday as questions about the effectiveness of one possible coronavirus vaccine..